Tirzepatide vs semaglutide: how to think about the choice

They share a class name, not a receptor profile. Tirzepatide delivers ~6 percentage points more average weight loss than semaglutide in pivotal trials. Tolerance, insurance coverage, and state stock often flip the decision anyway. Here's what to weigh before the provider call - and when the right answer is neither.